2019 - 2019
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Evaluation of the Global Vaccine Action Plan 2011-2020
MMGH supported the WHO Department of Immunisation, Vaccines and Biologicals (IVB) in the evaluation of strengths and weaknesses of the current Global Vaccine Action Plan (GVAP), its monitoring and evaluation and accountability framework, and the added value it provides to the global immunisation arena. The project included a comparative landscape analysis of global immunisation in 2010 and 2018, and a description of the overall progress on the plan’s goals and strategic objectives. In this project, MMGH partnered with the Task Force for Global Health.
Related Publication(s)
2019
Global Vaccine Action Plan 2011-2020 – Review and Lessons Learned: Strategic Advisory Group of Experts...
Abstract
The Global Vaccine Action Plan 2011–2020 (GVAP) was developed to help realise the vision of the Decade of Vaccines, that all individuals and communities enjoy lives free from vaccine-preventable diseases. As the decade draws to a close, it is time...
View Full Publication2020
Global Vaccine Action Plan Lessons Learned II: Stakeholder Perspectives...
Abstract
Introduction: The Global Vaccine Action Plan (GVAP), unanimously endorsed by the World Health Assembly in 2012, defined an ambitious strategy to improve immunisation. At the end of the decade, significant progress has been made but four of the five GVAP...
View Full Publication2020
Global Vaccine Action Plan Lessons Learned III: Monitoring and evaluation/accountability framework...
Abstract
Introduction: The Monitoring & Evaluation/Accountability (M&E/A) framework of the Global Vaccine Action Plan (GVAP) was used to report progress annually to the World Health Assembly (WHA). Methods: Stakeholder feedback was obtained through five reviews consisting of surveys and semi-structured interviews...
View Full Publication2020
The global vaccine action plan monitoring and evaluation/ accountability framework: Perspective...
Author
Thomas Cherian
Thomas Cherian
Abstract
The Monitoring & Evaluation/Accountability (M&E/A) framework to assess progress was a critical element of the Global Vaccine Action Plan 2012–2020 (GVAP) and was seen by many as a game changer. This article provides perspectives on the design and evolution of...
View Full Publication